Therapeutic Potential Regulatory T Cells - Digital Recording (October 1st, 2014)
ISCT Webinar: The Therapeutic Potential of Regulatory T Cells
Date: Wednesday, October 1st, 2014
Time: 9:00 AM PT, 11:00 AM CT, Noon PT, 6:00 PM CET (Central European Time)
Chair: Thomas Leemhuis, PhD, Division Director, Cellular Therapies, Hoxworth Blood Center, University of Cincinnati Academic Health Center (USA)
Speakers: Kevin Sheehan, PhD, BMT Program Scientific Director, Stanford University Medical Center, (USA) and Jo-Anna Reems, PhD, Scientific Director, Cell Therapy and Regenerative, University of Utah Cell Therapy Facility (USA)
About the Webinar:
- Define and characterize regulatory T cells functionally and phenotypically (and clarify nomenclature).
- Review current T reg isolation methods and discuss advantages and disadvantages of each.
- Review results from clinical trials testing the safety and efficacy of utilizing regulatory T cells for GVHD prevention or treatment and review other ongoing clinical trial applications.
- Stimulate ideas for additional clinical trial uses for regulatory T cells.